← Leaderboards
James C Root
Sloan-Kettering Inst Can Research
$5,068,428
Attributed
$9,589,452
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,589,452 · 5
By mechanism
R01$9,366,875 · 3
R03$177,000 · 1
P20$45,577 · 1
Top collaborators
- Tim Alan Ahles10 shared
- Jeanne Mandelblatt5 shared
- Andrew J Saykin5 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Kevin T Liou$990,335
Others in their field
Top investigators on “Cognitive”
- David R. Weir · University Of Michigan At Ann Arbor$380,402,429
- Paul S. Aisen · Cognition Therapeutics, Inc.$185,453,129
- Randall J Bateman · Washington University$179,917,643
- Reisa A. Sperling · Banner Health$160,454,465
- Michael W Weiner · Northern California Institute Res &Educ$153,571,751
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$118,618,221
Research focus
CognitiveCognitive FunctionSurvivorsInnovationCancer TherapyReportingCognitionResponseImpaired CognitionEnrollmentMalignant NeoplasmsBrainBreast Cancer PatientMeasurementAffectChemotherapyNeuropsychological TestsBasePerformanceCognitive ChangeCancer SurvivorBreast Cancer SurvivorCognitive NeuroscienceMalignant Breast Neoplasm
Grant awards (17)
Cognitive aging in long-term breast cancer survivors$731,063
R01 · FY2025 · CA · contact PI
Cognitive aging in long-term breast cancer survivors$696,066
R01 · FY2024 · CA · contact PI
Cognitive aging in long-term breast cancer survivors$731,058
R01 · FY2023 · CA · contact PI
Assessment of sensory gating, attention, and executive control in breast cancer$681,234
R01 · FY2022 · CA
Assessment of sensory gating, attention, and executive control in breast cancer$691,844
R01 · FY2021 · CA
Neural and Cognitive Mechanisms of Attention and Memory Deficits in Cancer Survivors$88,500
R03 · FY2021 · CA · contact PI
Assessment of sensory gating, attention, and executive control in breast cancer$843,444
R01 · FY2020 · CA
Older Breast Cancer Patients: Risk For Cognitive Decline$660,984
R01 · FY2020 · CA
Neural and Cognitive Mechanisms of Attention and Memory Deficits in Cancer Survivors$88,500
R03 · FY2020 · CA · contact PI
Older Breast Cancer Patients: Risk For Cognitive Decline$686,651
R01 · FY2019 · CA
Assessment of sensory gating, attention, and executive control in breast cancer$637,868
R01 · FY2019 · CA
Older Breast Cancer Patients: Risk For Cognitive Decline$724,682
R01 · FY2018 · CA
Assessment of sensory gating, attention, and executive control in breast cancer$687,576
R01 · FY2018 · CA
Older Breast Cancer Patients: Risk For Cognitive Decline$757,407
R01 · FY2017 · CA
Older Breast Cancer Patients: Risk For Cognitive Decline$836,998
R01 · FY2016 · CA
Project 1: Racial Differences in Attentional Bias and Cue Reactivity among Smokers$22,705
P20 · FY2015 · CA · contact PI
Project 1: Racial Differences in Attentional Bias and Cue Reactivity among Smokers$22,872
P20 · FY2014 · CA · contact PI